Christopher Holman

Adjunct Faculty
Primary office:


Chris Holman has been an associate professor at the University of Missouri-Kansas City School of Law since 2005. His primary research focus lies at the intersection of intellectual property and biotechnology. He has taught classes in patent law; intellectual property; food, drug and biotechnology law; antitrust and competition law; drug and medical technology torts; and property.

Prior to becoming a law professor, Holman served as vice-president of intellectual property and patent counsel at several Silicon Valley biotechnology companies and worked as an associate at a major intellectual property law firm. He was also a tenure-track chemistry professor in the California State University system.

A native of California, Holman received his Ph.D. in biochemistry and molecular biology from the University of California at Davis, and engaged in post-doctoral drug discovery research at Roche Biosciences in Palo Alto, Calif. He then attended law school at UC Berkeley’s Boalt Hall, during which time he was an associate editor for the Berkeley Technology Law Journal and served as a full-time judicial extern in federal court in the Northern District of California.

Courses Taught:
  • Intellectual Property


J.D., University of California, Berkeley, 1998; Ph.D., University of California, Davis, 1993; B.A., California State University, Hayward, 1987.


Intellectual Property

Career History

Assistant to Director of Intellectual Property and Licensing, Somatix Therapy Corporation, 1996; Patent Agent, Flehr Hohbach LLP, 1996-1997; Summer Associate and Associate, Pennie & Edmonds LLP, 1997, 1998-1999; Judicial Extern to Judge Claudia Wilken, Federal District Court, Northern District of California, 1997; Associate Patent Counsel, Transgenomic Inc., 2000-2001; Patent Counsel, Maxygen Inc., 2001-2002; Vice President of Intellectual Property, PhyNexus Inc., 2003-2005; Associate Professor, UMKC School of Law, 2005-present.

Representative Publications

"Will Gene Patents Derail the Next-Generation of Genetic Technologies?: A Reassessment of the Evidence Suggests Not," 80 UMKC Law Review 563 (2012); "Misplaced Fears in the Legislative Battle Over Affordable Biotech Drugs," 50 IDEA: The Journal of Law and Technology (2010, Energy Center Research Paper No. 12-01); "Learning from Litigation: What Can Lawsuits Teach Us About the Role of Human Gene Patents in Research and Innovation?" 18 Kansas Journal of Law & Public Policy 215 (2009); "The Impact of Human Gene Patents on Innovation and Access: A Survey of Human Gene Patent Litigation," 76 UMKC Law Review 295 (2007).